Meta-analyses: First-rank evidence or second-hand information?

Nature Reviews Cardiology

Volumn 8, Issue 5, 2011, Pages 249-251

  Zanchetti, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; NIFEDIPINE; PLACEBO; VERAPAMIL; ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; HUMAN; HYPERTENSION; LOW DRUG DOSE; META ANALYSIS; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; TREATMENT RESPONSE; BLOOD PRESSURE; DRUG EFFECT; EVIDENCE BASED MEDICINE; NOTE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; EVIDENCE-BASED MEDICINE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79955482432     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.39     Document Type: Article

References (10)

1. Messerli, F. H. et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring. A meta-analysis of randomized trials. J. Am. Coll. Cardiol. 57, 590-600 (2011).
2. Last, J. M. & Abramson, J. H. (Eds) A dictionary of epidemiology, 3rd edn (Oxford University Press, New York, 1995).
3. Zanchetti, A. et al. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS, a randomized double-blind trial. Stroke 35, 2807-2812 (2004).
4. Parati, G. & Mancia, G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J. Hypertens. 22, 435-445 (2004). (Pubitemid 38368472)
5. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 304, 405-412 (1992).
6. Hansson, L. et al. Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353, 611-616 (1999). (Pubitemid 29087980)
7. Hansson, L. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity: the Swedish Trial in Old Patients with Hypertension 2 study. Lancet 354, 1751-1756 (1999).
8. Brown, M. J. et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 356, 366-372 (2000). (Pubitemid 30487492)
9. Wing, L. M. et al. A comparison of outcomes with angiotensin converting enzyme inhibitors and diuretics for hypertension in the elderly. N. Engl. J. Med. 348, 583-592 (2003). (Pubitemid 36204952)
10. Black, H. R. et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 289, 2073-2082 (2003).